| Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF JP Bassand, G Accetta, AJ Camm, F Cools, DA Fitzmaurice, KAA Fox, ... European heart journal 37 (38), 2882-2889, 2016 | 297 | 2016 |
| Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation AJ Camm, G Accetta, G Ambrosio, D Atar, JP Bassand, E Berge, F Cools, ... Heart 103 (4), 307-314, 2017 | 290 | 2017 |
| International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT … BA Steinberg, H Gao, P Shrader, K Pieper, L Thomas, AJ Camm, ... American heart journal 194, 132-140, 2017 | 188 | 2017 |
| Quality of vitamin K antagonist control and 1-year outcomes in patients with atrial fibrillation: a global perspective from the GARFIELD-AF registry S Haas, H Ten Cate, G Accetta, P Angchaisuksiri, JP Bassand, AJ Camm, ... PloS one 11 (10), e0164076, 2016 | 173 | 2016 |
| Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without … KAA Fox, JE Lucas, KS Pieper, JP Bassand, AJ Camm, DA Fitzmaurice, ... BMJ open 7 (12), e017157, 2017 | 140 | 2017 |
| Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation JP Bassand, G Accetta, W Al Mahmeed, R Corbalan, J Eikelboom, ... PloS one 13 (1), e0191592, 2018 | 116 | 2018 |
| Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants AJ Camm, F Cools, S Virdone, JP Bassand, DA Fitzmaurice, ... Journal of the American College of Cardiology 76 (12), 1425-1436, 2020 | 109 | 2020 |
| Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ... Circulation 139 (6), 787-798, 2019 | 77 | 2019 |
| Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: real-world data from the GARFIELD-AF registry S Oh, S Goto, G Accetta, P Angchaisuksiri, AJ Camm, F Cools, S Haas, ... International journal of cardiology 223, 543-547, 2016 | 76 | 2016 |
| Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry PN Apenteng, H Gao, FDR Hobbs, DA Fitzmaurice BMJ open 8 (1), e018905, 2018 | 72 | 2018 |
| Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF S Haas, AJ Camm, JP Bassand, P Angchaisuksiri, F Cools, R Corbalan, ... American heart journal 213, 35-46, 2019 | 59 | 2019 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 59 | 2019 |
| Clinical outcomes in asymptomatic and symptomatic atrial fibrillation presentations in GARFIELD-AF: implications for AF screening H Gibbs, B Freedman, M Rosenqvist, S Virdone, W Al Mahmeed, ... The American Journal of Medicine 134 (7), 893-901. e11, 2021 | 45 | 2021 |
| Evolving quality standards for large-scale registries: the GARFIELD-AF experience KAA Fox, BJ Gersh, S Traore, A John Camm, G Kayani, A Krogh, ... European Heart Journal–Quality of Care and Clinical Outcomes 3 (2), 114-122, 2017 | 45 | 2017 |
| Analysis of outcomes in ischemic vs nonischemic cardiomyopathy in patients with atrial fibrillation: a report from the GARFIELD-AF registry R Corbalan, JP Bassand, L Illingworth, G Ambrosio, AJ Camm, ... JAMA cardiology 4 (6), 526-548, 2019 | 39 | 2019 |
| Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry FWA Verheugt, H Gao, W Al Mahmeed, G Ambrosio, P Angchaisuksiri, ... European heart journal 39 (6), 464-473, 2018 | 38 | 2018 |
| Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry AJ Camm, G Accetta, W Al Mahmeed, G Ambrosio, SZ Goldhaber, S Haas, ... BMJ open 7 (3), e014579, 2017 | 37 | 2017 |
| GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke JP Bassand, PN Apenteng, D Atar, AJ Camm, F Cools, R Corbalan, ... Future cardiology 17 (1), 19-38, 2020 | 34 | 2020 |
| Outcomes associated with oral anticoagulants plus antiplatelets in patients with newly diagnosed atrial fibrillation KAA Fox, P Velentgas, AJ Camm, JP Bassand, DA Fitzmaurice, BJ Gersh, ... JAMA Network Open 3 (2), e200107-e200107, 2020 | 31 | 2020 |
| The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events D Atar, E Berge, JY Le Heuzey, S Virdone, AJ Camm, J Steffel, H Gibbs, ... EP Europace 22 (2), 195-204, 2020 | 28 | 2020 |
